Welcome to Bayer Schering Pharma’s “From Targets To Novel Drugs” initiative
Dr. Kallio; University of
Turku, Finland:
“This program is a fantastic opportunity to forward pre-
clinical target discovery and validation. It can serve as an important bridge funding or allow execution of a few critical assays.”
read more
Turku, Finland:
“This program is a fantastic opportunity to forward pre-
clinical target discovery and validation. It can serve as an important bridge funding or allow execution of a few critical assays.”
read more
Our company’s mission is to provide new treatment options for diseases with high unmet medical need. We are committed to innovation and to translating ideas from basic research into novel drugs.
We are dedicated to fostering collaborations with excellent academic groups and start-ups. In order to further pool expertise and to join forces for mutual benefit, Bayer Schering Pharma AG intends to support collaborative research projects on attractive, novel molecular targets in the fields of To promote this new approach, Bayer Schering Pharma AG intends to allocate grants for the further development of promising targets. We look forward to hearing about your innovative ideas! On the following pages you will find more information on this initiative and the submission process. We will have two submission deadlines per year.
The next submission deadlines are September 30, 2010 and March 31, 2011.
We are dedicated to fostering collaborations with excellent academic groups and start-ups. In order to further pool expertise and to join forces for mutual benefit, Bayer Schering Pharma AG intends to support collaborative research projects on attractive, novel molecular targets in the fields of To promote this new approach, Bayer Schering Pharma AG intends to allocate grants for the further development of promising targets. We look forward to hearing about your innovative ideas! On the following pages you will find more information on this initiative and the submission process. We will have two submission deadlines per year.
The next submission deadlines are September 30, 2010 and March 31, 2011.